Medtronic, Aetna Partner On Insulin Pump Cost-Savings Program
This article was originally published in The Gray Sheet
The device maker and insurance provider are collaborating to provide discounted Medtronic insulin pumps to Aetna members who have uncontrolled type 2 diabetes.
You may also be interested in...
Medtronic's outcomes-based insulin pump supply deal with Aetna is the latest example of the medtech industry's shift toward value-based care.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.